Medication

Mike, right, and Becky Shamo, left, the parents of Aaron Shamo, walk with another family member as they leave the federal courthouse Thursday, Aug. 29, 2019, Salt Lake City. A jury is deliberating in the case of a Utah man accused of running a multimillion-dollar opioid ring that shipped fake prescription drugs across the country, causing at least one fatal overdose. Prosecutors said during closing arguments that Aaron Shamo's operation helped fuel the nation's opioid epidemic by making hundreds of thousands of pills available to addicts and other users. (AP Photo/Rick Bowmer)
August 29, 2019 - 8:44 pm
SALT LAKE CITY (AP) — A jury began deliberating Thursday in the case of a Utah man accused of running a multimillion-dollar opioid ring that shipped potentially poisonous, fake prescription drugs across the country, causing at least one fatal overdose. Prosecutors said during closing arguments that...
Read More
FILE - In this Thursday, March 14, 2008 file photo, a woman rides a bicycle past Changzhou SPL in Changzhou, China. The FDA did not open its first permanent offices in China and India until 2008 and 2009, respectively. That followed dozens of deaths and hundreds of allergic reactions in the U.S. linked to the contaminated blood thinner heparin made at this Chinese facility. (AP Photo/Eugene Hoshiko)
August 28, 2019 - 10:44 pm
WASHINGTON (AP) — U.S. health officials on Wednesday tried to reassure patients that they face very low risks from ongoing contamination problems with widely prescribed blood pressure drugs. Drugmakers have issued more than 50 recalls since last July linked to low levels of a probable cancer-...
Read More
FILE - This Feb. 19, 2013 file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. State attorneys general and lawyers representing local governments said Tuesday, Aug. 27, 2019, they are in active negotiations with Purdue Pharma, maker of the prescription painkiller OxyContin, as they attempt to reach a landmark settlement over the nation's opioid crisis. (AP Photo/Toby Talbot, File)
August 28, 2019 - 9:10 am
COLUMBUS, Ohio (AP) — States and local governments are in talks to settle lawsuits with the maker of the prescription painkiller OxyContin that is facing billions of dollars in potential liability for its role in the nation's opioid crisis. Suits filed by more than 2,000 state, local and tribal...
Read More
FILE - This Feb. 19, 2013 file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. State attorneys general and lawyers representing local governments said Tuesday, Aug. 27, 2019, they are in active negotiations with Purdue Pharma, maker of the prescription painkiller OxyContin, as they attempt to reach a landmark settlement over the nation's opioid crisis. (AP Photo/Toby Talbot, File)
Associated Press
August 28, 2019 - 4:24 am
COLUMBUS, Ohio (AP) — State attorneys general and lawyers representing local governments said Tuesday they are in active settlement talks with Purdue Pharma, the maker of the prescription painkiller OxyContin that is facing billions of dollars in potential liability for its role in the nation's...
Read More
FILE - In this Jan. 4, 2018, file photo, cannabis consultant Juan Aguilar, left, assists customers Bill, right, and Nize Nylen and their son Russell shop for edible marijuana products in the Herban Legends pot shop in Seattle. Five years after Washington launched its pioneering legal marijuana market, officials are proposing their most ambitious overhaul yet of the way the industry is regulated, with plans for boosting minority ownership of pot businesses, spreading out oversight among a range of state agencies, and letting the smallest cannabis producers increase the size of the operations in an effort to help them become more competitive. (AP Photo/Elaine Thompson, File)
August 27, 2019 - 4:13 pm
SEATTLE (AP) — Five years after Washington launched its pioneering legal marijuana market, officials are proposing an overhaul of the state's industry rules, with plans for boosting minority ownership of pot businesses, paving the way for home deliveries of medical cannabis and letting the smallest...
Read More
Judge Thad Balkman enters the courtroom before he delivers his decision in the opioid trial at the Cleveland County Courthouse in Norman, Okla., Monday, Aug. 26, 2019. Balkman ruled in favor of the state of Oklahoma and ordered Johnson and Johnson to pay $572 million to a plan to abate the opioid crisis. (Chris Landsberger/The Oklahoman via AP, Pool)
August 27, 2019 - 2:38 pm
Johnson & Johnson investors exhaled in relief Tuesday, pushing up the company's shares after an Oklahoma judge imposed a $572 million verdict for the health care giant's role in the nation's opioid crisis. During the seven week trial, state prosecutors who sought up to $17 billion described J...
Read More
FILE - In this Nov. 5, 2018 file photo, a drugstore employee reaches for medicine from shelf in downtown Tehran, Iran. According to a study published in the British journal Lancet on Thursday, Aug. 22, 2019, researchers say a cheap daily pill that combines four drugs cut the risk of heart attacks, strokes and heart failure in a large study, suggesting it could be a good way to prevent heart problems. (AP Photo/Ebrahim Noroozi)
August 23, 2019 - 12:12 am
LONDON (AP) — A cheap daily pill that combines four drugs cut the risk of heart attacks, strokes and heart failure in a large study, suggesting it could be a good way to help prevent heart problems especially in poor countries. The pills contained two blood pressure drugs, a cholesterol medicine...
Read More
August 20, 2019 - 5:17 pm
Two pharmaceutical companies have reached settlements totaling $15 million to avoid being defendants in the first federal trial on the drug industry's accountability for a nationwide opioid crisis. Dublin, Ireland-based Endo Pharmaceuticals announced Tuesday that it has agreed to pay the Ohio...
Read More
FILE- In this July 10, 2018, file photo bottles of medicine ride on a belt at a mail-in pharmacy warehouse in Florence, N.J. Drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to, according to an Associated Press analysis. (AP Photo/Julio Cortez, File)
August 19, 2019 - 3:00 pm
TRENTON, N.J. (AP) — Drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to. That's according to an Associated Press analysis of drug prices provided by health information firm Elsevier. After years of frequent list price hikes...
Read More
Thomas Uhle, grow manager, tends to marijuana plants growing at GB Sciences Louisiana, in Baton Rouge, La., Tuesday, Aug. 6, 2019. Today was the first day the marijuana, which was grown for medical purposes, was processed and shipped to patients in Louisiana. (AP Photo/Gerald Herbert)
August 19, 2019 - 2:38 pm
BATON ROUGE, La. (AP) — Two weeks after Louisiana patients began receiving medical marijuana, the program is humming along without supply disruption and with thousands of people receiving the drug for medical use, regulatory officials and the head of one growing operation said Monday. John Davis,...
Read More

Pages